CME Group Inc. Expected to Post FY2025 Earnings of $9.49 Per Share (NASDAQ:CME)

CME Group Inc. (NASDAQ:CME - Free Report) - Investment analysts at Zacks Research boosted their FY2025 EPS estimates for shares of CME Group in a research note issued on Wednesday, May 15th. Zacks Research analyst T. De now expects that the financial services provider will earn $9.49 per share for the year, up from their previous forecast of $9.34. The consensus estimate for CME Group's current full-year earnings is $9.72 per share.

A number of other brokerages have also issued reports on CME. Barclays raised their target price on shares of CME Group from $226.00 to $228.00 and gave the stock an "equal weight" rating in a research report on Thursday, April 25th. Bank of America boosted their target price on CME Group from $209.00 to $216.00 and gave the stock a "neutral" rating in a research report on Thursday, April 25th. Keefe, Bruyette & Woods raised their price target on CME Group from $222.00 to $226.00 and gave the company a "market perform" rating in a research report on Thursday, April 25th. Argus boosted their price objective on shares of CME Group from $225.00 to $245.00 and gave the stock a "buy" rating in a research report on Wednesday, March 6th. Finally, JPMorgan Chase & Co. raised their target price on shares of CME Group from $198.00 to $206.00 and gave the company a "neutral" rating in a report on Thursday, April 25th. Two equities research analysts have rated the stock with a sell rating, seven have issued a hold rating and two have assigned a buy rating to the company. According to MarketBeat, CME Group presently has an average rating of "Hold" and an average target price of $217.80.

CME Group Stock Up 0.2 %

CME stock traded up $0.41 during midday trading on Friday, reaching $213.14. 1,466,362 shares of the company were exchanged, compared to its average volume of 1,776,864. The stock's 50-day simple moving average is $212.46 and its 200 day simple moving average is $211.32. The company has a debt-to-equity ratio of 0.10, a quick ratio of 1.01 and a current ratio of 1.01. CME Group has a 1-year low of $175.73 and a 1-year high of $223.80. The company has a market cap of $76.75 billion, a price-to-earnings ratio of 24.25, a price-to-earnings-growth ratio of 5.51 and a beta of 0.48.

CME Group (NASDAQ:CME - Get Free Report) last released its quarterly earnings data on Wednesday, April 24th. The financial services provider reported $2.50 earnings per share (EPS) for the quarter, topping the consensus estimate of $2.44 by $0.06. CME Group had a net margin of 56.84% and a return on equity of 12.45%. The business had revenue of $1.49 billion during the quarter, compared to analysts' expectations of $1.48 billion. During the same period in the previous year, the company earned $2.42 EPS. The company's revenue for the quarter was up 3.2% on a year-over-year basis.

Institutional Inflows and Outflows

A number of large investors have recently modified their holdings of CME. Gold Investment Management Ltd. bought a new position in shares of CME Group in the fourth quarter valued at $26,000. Salomon & Ludwin LLC acquired a new stake in CME Group during the 1st quarter worth about $28,000. OFI Invest Asset Management purchased a new position in shares of CME Group in the third quarter worth approximately $25,000. Northwest Financial Advisors acquired a new stake in shares of CME Group during the fourth quarter valued at approximately $28,000. Finally, Harbor Investment Advisory LLC lifted its position in shares of CME Group by 966.7% in the 4th quarter. Harbor Investment Advisory LLC now owns 160 shares of the financial services provider's stock valued at $34,000 after acquiring an additional 145 shares in the last quarter. 87.75% of the stock is owned by institutional investors and hedge funds.

Insiders Place Their Bets

In other CME Group news, Director Terry L. Savage sold 2,500 shares of CME Group stock in a transaction that occurred on Monday, May 13th. The stock was sold at an average price of $210.65, for a total transaction of $526,625.00. Following the sale, the director now directly owns 17,441 shares in the company, valued at approximately $3,673,946.65. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. In other CME Group news, Director Terry L. Savage sold 2,500 shares of the firm's stock in a transaction dated Monday, May 13th. The shares were sold at an average price of $210.65, for a total value of $526,625.00. Following the transaction, the director now owns 17,441 shares of the company's stock, valued at $3,673,946.65. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, insider Hilda Harris Piell sold 7,140 shares of CME Group stock in a transaction dated Wednesday, May 8th. The shares were sold at an average price of $210.35, for a total transaction of $1,501,899.00. Following the completion of the sale, the insider now owns 29,256 shares in the company, valued at $6,153,999.60. The disclosure for this sale can be found here. Insiders sold a total of 49,640 shares of company stock worth $10,464,924 in the last 90 days. 0.30% of the stock is owned by company insiders.

CME Group Announces Dividend

The business also recently declared a quarterly dividend, which will be paid on Tuesday, June 25th. Investors of record on Friday, June 7th will be given a dividend of $1.15 per share. This represents a $4.60 annualized dividend and a yield of 2.16%. The ex-dividend date of this dividend is Friday, June 7th. CME Group's dividend payout ratio (DPR) is presently 52.33%.

CME Group Company Profile

CME Group Inc, together with its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers futures and options products based on interest rates, equity indexes, foreign exchange, agricultural commodities, energy, and metals, as well as fixed income and foreign currency trading services.